These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32569126)

  • 1. Effect of Caffeine on Endurance Performance in Athletes May Depend on HTR2A and CYP1A2 Genotypes.
    Guest NS; Corey P; Tyrrell PN; El-Sohemy A
    J Strength Cond Res; 2022 Sep; 36(9):2486-2492. PubMed ID: 32569126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP1A2 Genotype Modifies the Effects of Caffeine Compared With Placebo on Muscle Strength in Competitive Male Athletes.
    Wong O; Marshall K; Sicova M; Guest NS; García-Bailo B; El-Sohemy A
    Int J Sport Nutr Exerc Metab; 2021 Sep; 31(5):420-426. PubMed ID: 34284351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine, CYP1A2 Genotype, and Endurance Performance in Athletes.
    Guest N; Corey P; Vescovi J; El-Sohemy A
    Med Sci Sports Exerc; 2018 Aug; 50(8):1570-1578. PubMed ID: 29509641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeine, genetic variation and anaerobic performance in male athletes: a randomized controlled trial.
    Sicova M; Guest NS; Tyrrell PN; El-Sohemy A
    Eur J Appl Physiol; 2021 Dec; 121(12):3499-3513. PubMed ID: 34529114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does ergogenic effect of caffeine supplementation depend on CYP1A2 genotypes? A systematic review with meta-analysis.
    Wang J; Dewi L; Peng Y; Hou CW; Song Y; Condello G
    J Sport Health Sci; 2024 Jul; 13(4):499-508. PubMed ID: 38158179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of
    Muñoz A; López-Samanes Á; Aguilar-Navarro M; Varillas-Delgado D; Rivilla-García J; Moreno-Pérez V; Del Coso J
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32823594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine and 3-km cycling performance: Effects of mouth rinsing, genotype, and time of day.
    Pataky MW; Womack CJ; Saunders MJ; Goffe JL; D'Lugos AC; El-Sohemy A; Luden ND
    Scand J Med Sci Sports; 2016 Jun; 26(6):613-9. PubMed ID: 26062916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of CYP1A2 genotype on the ergogenic properties of caffeine during resistance exercise: a randomized, double-blind, placebo-controlled, crossover study.
    Rahimi R
    Ir J Med Sci; 2019 Feb; 188(1):337-345. PubMed ID: 29532291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeine, exercise physiology, and time-trial performance: no effect of
    Glaister M; Chopra K; Pereira De Sena AL; Sternbach C; Morina L; Mavrommatis Y
    Appl Physiol Nutr Metab; 2021 Jun; 46(6):541-551. PubMed ID: 33170731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of caffeine on cognitive performance is influenced by CYP1A2 but not ADORA2A genotype, yet neither genotype affects exercise performance in healthy adults.
    Carswell AT; Howland K; Martinez-Gonzalez B; Baron P; Davison G
    Eur J Appl Physiol; 2020 Jul; 120(7):1495-1508. PubMed ID: 32356023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP1A2 genotype and acute effects of caffeine on resistance exercise, jumping, and sprinting performance.
    Grgic J; Pickering C; Bishop DJ; Schoenfeld BJ; Mikulic P; Pedisic Z
    J Int Soc Sports Nutr; 2020 Apr; 17(1):21. PubMed ID: 32295624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of caffeine on exercise performance is not influenced by ADORA2A genotypes, alone or pooled with CYP1A2 genotypes, in adolescent athletes.
    Dos Santos MPP; Spineli H; Dos Santos BP; Lima-Silva AE; Gitaí DLG; Bishop DJ; de Araujo GG
    Eur J Nutr; 2023 Mar; 62(2):1041-1050. PubMed ID: 36385314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine, CYP1A2 Genotype, and Exercise Performance: A Systematic Review and Meta-analysis.
    Barreto G; Esteves GP; Marticorena F; Oliveira TN; Grgic J; Saunders B
    Med Sci Sports Exerc; 2024 Feb; 56(2):328-339. PubMed ID: 37844569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP1A2 Genotype Variations Do Not Modify the Benefits and Drawbacks of Caffeine during Exercise: A Pilot Study.
    Salinero JJ; Lara B; Ruiz-Vicente D; Areces F; Puente-Torres C; Gallo-Salazar C; Pascual T; Del Coso J
    Nutrients; 2017 Mar; 9(3):. PubMed ID: 28287486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine improves various aspects of athletic performance in adolescents independent of their 163 C > A CYP1A2 genotypes.
    Spineli H; Pinto MP; Dos Santos BP; Lima-Silva AE; Bertuzzi R; Gitaí DLG; de Araujo GG
    Scand J Med Sci Sports; 2020 Oct; 30(10):1869-1877. PubMed ID: 32538495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can the Brazilian Caffeine Expectancy Questionnaires Differentiate the
    Mendes GF; Reis CEG; Nakano EY; Spineli H; Barreto G; Noronha NY; Watanabe LM; Nonino CB; de Araujo GG; Saunders B; Zandonadi RP
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP1A2 genotype and acute ergogenic effects of caffeine intake on exercise performance: a systematic review.
    Grgic J; Pickering C; Del Coso J; Schoenfeld BJ; Mikulic P
    Eur J Nutr; 2021 Apr; 60(3):1181-1195. PubMed ID: 33137206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP1A2 Genetic Variation, Coffee Intake, and Kidney Dysfunction.
    Mahdavi S; Palatini P; El-Sohemy A
    JAMA Netw Open; 2023 Jan; 6(1):e2247868. PubMed ID: 36701157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Genetics in Moderating the Inter-Individual Differences in the Ergogenicity of Caffeine.
    Southward K; Rutherfurd-Markwick K; Badenhorst C; Ali A
    Nutrients; 2018 Sep; 10(10):. PubMed ID: 30248915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of serotonin 2A receptor and lack of association of CYP1A2 gene polymorphism with tardive dyskinesia in a Turkish population.
    Boke O; Gunes S; Kara N; Aker S; Sahin AR; Basar Y; Bagci H
    DNA Cell Biol; 2007 Aug; 26(8):527-31. PubMed ID: 17688403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.